Stan Berenshteyn
Stock Analyst at Wells Fargo
(0.55)
# 2334
Out of 5,329 analysts
65
Total ratings
40.00%
Success rate
-5.95%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GDRX GoodRx Holdings | Maintains: Overweight | 8 7 | 4.64 | 50.86% | 8 | Apr 29, 2025 | |
OMCL Omnicell | Maintains: Equal-Weight | 40 38 | 31.43 | 20.9% | 13 | Apr 17, 2025 | |
HQY HealthEquity | Maintains: Overweight | 110 125 | 88.24 | 41.66% | 9 | Feb 26, 2025 | |
DOCS Doximity | Maintains: Equal-Weight | 43 55 | 58.11 | -5.35% | 10 | Feb 7, 2025 | |
HCAT Health Catalyst | Maintains: Overweight | 13 10 | 4 | 150% | 5 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 15 15 | 6.25 | 140% | 3 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 275 285 | 232.26 | 22.71% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | n/a | n/a | 10 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 28 23 | 6.99 | 229.04% | 2 | Mar 6, 2023 |